{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:41:58Z","timestamp":1787312518197,"version":"build-2736575974"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jocn.2019.11.038","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T08:06:31Z","timestamp":1577433991000},"page":"271-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy"],"prefix":"10.1016","volume":"71","author":[{"given":"Tia R.A.","family":"Ozarczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lay K.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolandi","family":"vanHeerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jocn.2019.11.038_b0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.6004\/jnccn.2019.0013","article-title":"Management of immunotherapy-related toxicities, version 1.2019","volume":"17","author":"Thompson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.jocn.2019.11.038_b0010","first-page":"e985","article-title":"Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer","volume":"9","author":"Touat","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.11.038_b0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1212\/WNL.0000000000007235","article-title":"Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies","volume":"92","author":"Johansen","year":"2019","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jocn.2019.11.038_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000535","article-title":"Inflammatory myopathy with myasthenia gravis: thymoma association and polymyositis pathology","volume":"6","author":"Uchio","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.jocn.2019.11.038_b0025","first-page":"286","article-title":"Atrophy of bilateral extraocular muscles: CT and clinical features of seven patients","volume":"16","author":"Okamoto","year":"1996","journal-title":"Neuroophthalmology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819313001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819313001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:19:03Z","timestamp":1760822343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819313001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":5,"alternative-id":["S0967586819313001"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.11.038","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}